{"schema_version":"secwatch.filing_event.v1","accession":"0001104659-26-066021","form_type":"8-K","ticker":"EDIT","cik":"0001650664","company_name":"Editas Medicine, Inc.","filed_at":"2026-05-26T12:07:16+00:00","discovered_at":"2026-05-26T12:10:02.424579+00:00","generated_at":"2026-05-26T12:10:28.373549+00:00","sec_items":["8.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.3,"confidence":"high","headline":"Editas Medicine suspends ATM offering program; $43.9M raised to date","bullets":["Notified TD Cowen of suspension and termination of March 21, 2025 prospectus supplement.","No further ATM sales until new prospectus or registration statement is filed and effective.","Sales Agreement with TD Cowen remains in full force and effect.","Aggregate sales to date: 14,327,365 shares for $43.9M gross proceeds before expenses."],"urls":{"canonical":"https://secwatch.observer/filing/0001104659-26-066021","json":"https://secwatch.observer/filing/0001104659-26-066021.json","markdown":"https://secwatch.observer/filing/0001104659-26-066021.md","text":"https://secwatch.observer/filing/0001104659-26-066021.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1650664/000110465926066021/0001104659-26-066021-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1650664/000110465926066021/tm2615565d2_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-26T12:10:28.373549+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}